94828-31-6

Basic information

• Product Name: 2-Buten-1-ol, 2-methyl-4-(2,3,4,5-tetramethoxy-6-methylphenyl)-, (E)-
• CAS NO: 94828-31-6
• Molecular Formula: C16H24O5
• Molecular Weight: 296.364
• Mol File: 94828-31-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-Buten-1-ol, 2-methyl-4-(2,3,4,5-tetramethoxy-6-methylphenyl)-, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Buten-1-ol, 2-methyl-4-(2,3,4,5-tetramethoxy-6-methylphenyl)-, (E)-(94828-31-6)
• EPA Substance Registry System: 2-Buten-1-ol, 2-methyl-4-(2,3,4,5-tetramethoxy-6-methylphenyl)-, (E)-(94828-31-6)

Safety Data

• Hazardous Substances Data: 94828-31-6(Hazardous Substances Data)

Upstream product

• 71573-66-5 1‐allyl‐2,3,4,5‐tetramethoxy‐6‐methylbenzene 
• 73875-27-1 2,3,4,5-tetramethoxy-6-methyl-1-bromobenzene 
• 83036-56-0 1,2,3,4-tetramethoxy-5-methyl-6-(3-methylbut-2-en-1-yl)benzene 
• 94828-24-7 1,2,3,4-Tetramethoxy-5-methyl-6-(3-methyl-2-phenylsulfanyl-but-3-enyl)-benzene 

Downstream Products

• 94828-16-7 1-(5'-p-tosyl-all-trans-decaprenyl)-2-methyl-3,4,5,6-tetramethoxybenzene 
• 94828-18-9 1-((2E,5E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-tetraconta-2,5,10,14,18,22,26,30,34,38-decaenyl)-2,3,4,5-tetramethoxy-6-methyl-benzene 
• 94828-17-8 (2'E,6'E,10'E,14'E,18'E,22'E,26'E,30'E,34'E,38'E)-1-(3',7',11',15',19',23',27',31',35',39'-decamethyltetraconta-2',6',10',14',18',22',26',30',34',38'-decaenyl)-6-methyl-2,3,4,5-tetramethoxybenzene 
• 94827-96-0 2-((2E,5E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-tetraconta-2,5,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methyl-[1,4]benzoquinone 
• 303-98-0 ubidecarenone 
• 94828-11-2 1-((E)-4-Bromo-3-methyl-but-2-enyl)-2,3,4,5-tetramethoxy-6-methyl-benzene 

Relevant articles and documents

Preparation of key intermediates for the syntheses of coenzyme Q10 and derivatives by cross-metathesis reactions

An alternative catalytic strategy for the preparation of benzylmethacrylate esters, key intermediates in the synthesis of coenzyme Q10 and derivatives, was reported. This strategy avoided undesirable stoichiometric reduction/oxidation processes by utilizi